hotspot -WSS

hotspot

author：comprehensive 2025-09-29 19:57:36 - browse：641

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Multiple sclerosis has subtypes with different best treatments: study

focus

explore

knowledge

WSS

Mass General Brigham physicians react to latest merger step

U.K. decision on ALS drug has neurologists, advocates up in arms

Oral obesity drug from Viking Therapeutics hits key early target

Insurer loopholes limit power of law against surprise medical bills

Covid silver lining: Unprecedented look at human immune system

Hundreds died while taking an arthritis drug, but nobody alerted patients

Wikipedia

hotspot

knowledge

Jerome Adams on the need for new antivirals for Covid

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Oral obesity drug from Viking Therapeutics hits key early target

Virginia high school admissions case could be legal follow

U.K. decision on ALS drug has neurologists, advocates up in arms

State Dept. review finds Biden bears some blame for Afghanistan failures

Pancreatic cancer is often deadly, but new discoveries are raising hope

Psychedelics group wrestles with new pharma identity

Scientific mystery highlights the blind spots in genomics databases

focus

Mass General Brigham physicians react to latest merger step

Pancreatic cancer is often deadly, but new discoveries are raising hope

Gut bacteria may contribute to kidney autoimmunity, study finds

Overprescribed: High cost isn't America's only drug problem

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Gut bacteria may contribute to kidney autoimmunity, study finds

focus

explore

knowledge

entertainment